Be A Biotechnology Analyst

We do not intend to belittle the outstanding work that research analysts perform or to underestimate their training and experience. Nevertheless, our experience indicates that investors often have a better sense of the likelihood of the occurrence of a particular event (e.g. the success of a clinical trial, the FDA's approval of a product, etc.) compared to research analysts. This can be attributed partly to the fact that investors are often more objective in their analysis because they are detached from the event.

In this section, we request that you behave as an analyst and express your view regarding the possible outcome of an event. We will rotate the questions, monitor the results, and provide feedback to the greater biotech community.